Laxative Agent

PreclinicalSmall molecule

AAir Force Military Medical University, China

Laxative Agent is one of 5 small molecule programs targeting Chronic constipation. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chronic ConstipationActive, not recruiting

Chronic ConstipationPreclinical

Active, not recruiting

Competition

Competitive Landscape

7 competitors in Chronic Constipation

#DrugCompanyPhaseTrials

Resotran

Takeda

Approved

17 2

Golytely

Bayer

Approved

1 3

Ornidazole

AAssistance Publique - Hôpitaux de Paris

Preclinical

1 4

Phage

OOttawa Hospital Research Institute

Preclinical

1 5

Laxative Agent

AAir Force Military Medical University, China

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Chronic constipation1 trial

Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Chronic Constipation

Terminated·—·N/A·NCT05723731·106 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Laxative Agent. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Laxative Agent compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Laxative Agent. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Air Force Military Medical University, China company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAir Force Military Medical University, China

Laxative Agent

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Chronic constipation1 trial

References

Drug Info

Quick Facts

Related News